Back to UBS Group AG UBS Group AG

ESLAESLA
10 quarters

Position history for UBS Group AGUBS Group AG's holdings in ESTRELLA IMMUNOPHARMA INC

UBS Group AG holds 1,721 shares of ESLA (ESTRELLA IMMUNOPHARMA INC), worth $1,790 as of 2026-Q2. The position was decreased (-88.6% shares).

Current Value

$1,790

Current Shares

1,721

Total Value Change

+$1,454

Total Shares Change

+1,418

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1,721
-88.6%
$1,7900.0%$1.04
0
2026-Q1
Increased
15,079
+373.1%
$15,9830.0%$1.09
20
2025-Q4
Decreased
3,187
-93.7%
$4,9710.0%$1.53
0
2025-Q3
Decreased
50,347
-30.8%
$57,8990.0%$1.19
0
2025-Q2
Increased
72,773
+77.3%
$69,8620.0%$0.88
22
2025-Q1
Decreased
41,034
-37.0%
$38,0380.0%$0.92
0
2024-Q4
Increased
65,167
+899.0%
$78,2010.0%$1.24
23
2024-Q3
New
6,523
-
$7,5670.0%$1.19
25
2024-Q1
Exited
0
-100.0%
$00.0%$1.24
0
2023-Q4
New
303
-
$3360.0%$1.11
17

Other major holders of ESLA: VANGUARD GROUP INC, VANGUARD CAPITAL MANAGEMENT LLC, WELLS FARGO & COMPANY/MN

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used